Literature DB >> 3813592

A case-control study of possible causative factors in mycosis fungoides.

E Tuyp, A Burgoyne, T Aitchison, R MacKie.   

Abstract

A detailed case control study was carried out on 53 patients (33 males and 20 females) with histologically proven mycosis fungoides and on an age- and sex-matched control population. Possible causative factors investigated included occupation, recreation, and exposure to petrochemicals, pesticides, insecticides, and potential carcinogens. Exposure to plants of the Compositae family, tanning history, and chronic sun exposure were also investigated, as were smoking history, drug ingestion history, and other skin disease. Personal and family histories of other malignancies were also investigated. The only statistically significant difference to emerge was that the patients with mycosis fungoides had significantly more family history of atopic dermatitis. In view of the absence of any significant difference between patients and controls with regard to personal history of atopic dermatitis, this difference may be the result of multiple statistical testing rather than a phenomenon of true biological significance.

Entities:  

Mesh:

Year:  1987        PMID: 3813592

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

1.  Peripheral T-cell lymphoma and Job's syndrome: a rare association.

Authors:  Ibrahim K Onal; Mevlut Kurt; Kadri Altundag; Sercan Aksoy; Murat Dincer; Ibrahim Gullu
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 2.  Infectious agents in cutaneous T-cell lymphoma.

Authors:  Ezra D Mirvish; Rebecca G Pomerantz; Larisa J Geskin
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

3.  Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Briseis Aschebrook-Kilfoy; Pierluigi Cocco; Carlo La Vecchia; Ellen T Chang; Claire M Vajdic; Marshall E Kadin; John J Spinelli; Lindsay M Morton; Eleanor V Kane; Joshua N Sampson; Carol Kasten; Andrew L Feldman; Sophia S Wang; Yawei Zhang
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 4.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

5.  Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study.

Authors:  J Iscovich; O Paltiel; E Azizi; A Kuten; A Gat; B Lifzchitz-Mercer; A Zlotogorski; A Polliack
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

6.  Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).

Authors:  M Thayu; G Tallini; E J Glusac; B M Kacinski; L D Wilson
Journal:  Yale J Biol Med       Date:  1999 Nov-Dec

Review 7.  Update on Biology of Cutaneous T-Cell Lymphoma.

Authors:  Zaw H Phyo; Satish Shanbhag; Sima Rozati
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

Review 8.  Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Charlotte Menne Bonefeld; Mariusz A Wasik; Sergei B Koralov; Carsten Geisler; Mogens Kilian; Lars Iversen; Anders Woetmann; Niels Odum
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

9.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.